Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @RocheSequencing
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @RocheSequencing
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Come and visit our booth 701 at
#ASHG19 to learn about our Next Generation Sequencing#TargetEnrichment portfolio.#genomicspic.twitter.com/9FN4FEh4iH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Don’t miss an exciting symposium together with
@GEHealthcare at#ISUOG2019 on#Ultrasound and#NIPT: synergistic strategies for your practice. 15 Oct, 2019, 13:00 – 14:00, Convention Hall D. Learn morehttp://bit.ly/2BbyTLtHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are at
#ISUOG2019 in Berlin, Germany. Stop by Roche booth 9 and learn about#NIPT solutions. Join our symposium and poster presentations. Learn more http://bit.ly/2BbyTLt pic.twitter.com/LafyM77sbH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Visit Roche booth 303 to learn more about our NGS solutions for comprehensive genomic profiling, surveillance and monitoring
#ESMO19Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Please join Roche for a poster presentation at
#ESMO19 "Enhanced Access to EGFR Molecular Testing in NSCLC using a Cell-Free DNA Tube for Liquid Biopsy" 30 Sept | 1416Phttp://bit.ly/2mDfwqvHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#LiquidBiopsy can improve patient access to targeted therapies. Visit Roche booth 303 at#ESMO19 to learn more.http://bit.ly/2mDfwqvHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Come see Roche's poster presentation "An exploratory analysis of on-treatment ctDNA measurement as a potential surrogate for overall survival for atezolizumab benefit in the OAK Study" 28 Sept at 12:00 | 1559P
#ESMO19http://bit.ly/2mDfwqvHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check out Roche's poster presentation "Mutational profiling of tumor tissue and sequential plasma illustrates emergent clones during treatment in late stage small cell lung cancer (SCLC)" 28 Sept at 12:00 | 1744P
#ESMO19http://bit.ly/2mDfwqvHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Visit Roche during our poster presentation "Disease monitoring of EGFR mutation-positive NSCLC patients via circulating tumor DNA" 28 Sept at 12:00 | 1560P
#ESMO19http://bit.ly/2mDfwqvHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn about the only companion diagnostic
#LiquidBiopsy that's FDA-approved for non-small cell lung cancer (NSCLC) at Roche booth 303#ESMO19http://bit.ly/2mDfwqvHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Come visit Roche Diagnostics at booth 303 to hear more about our
#oncology solutions#ESMO19 http://bit.ly/2mDfwqv pic.twitter.com/JDRV24OQ4n
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Visit Roche booth 400 at
#WCLC19 to learn more about the NAVIFY Mutation Profiler and see a#LiveDemo . Learn more athttp://bit.ly/2kv7ortHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Visit Roche during our poster presentation "Early Assessment of Therapy Response in Non-small Cell Lung Cancer (NSCLC) via Longitudinal ctDNA Analysis" Poster 2795 | 9 Sept
#WCLC19Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Come see Roche's poster "Assessing the impact of clonal hematopoiesis in disease monitoring using targeted cell-free DNA (cfDNA) sequencing technology" Poster 2864 | 8 Sept
#WCLC19Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn more about the only FDA-approved
#LiquidBiopsy#CompanionDiagnostics for#NSCLC at Roche booth 400 at#WCLC19 Learn more athttp://bit.ly/2kv7ortHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ask our
#informatics experts about what Roche is doing to overcome challenges in clinical NGS reporting at booth 400#WCLC19 Learn more athttp://bit.ly/2kv7ortHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Don't miss the Roche Scientific Symposium on "Clinical Value of Diagnostic Agility in Managing Patients with Lung Cancer" 7 Sept, 7:30-11:30
#WCLC19 http://bit.ly/2klyFwEHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Visit Roche booth 400 at
#WCLC19 to learn more about our broad portfolio of oncology diagnostic solutions. Learn more at:http://bit.ly/2kv7ortHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.